We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

1in3

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1in3.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:1in3.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1in3| PDB=1in3 | SCENE= }}
{{STRUCTURE_1in3| PDB=1in3 | SCENE= }}
-
'''Peptide Antagonist of IGFBP1, (i,i+8) Covalently Restrained Analog'''
+
===Peptide Antagonist of IGFBP1, (i,i+8) Covalently Restrained Analog===
-
==Overview==
+
<!--
-
Highly structured, peptide antagonists of the interaction between insulin-like growth factor 1 (IGF-I) and IGF binding protein 1 (IGFBP-1) have recently been discovered by phage display of naive peptide libraries [Lowman, H. B., et al. (1998) Biochemistry 37, 8870--8878]. We now report a detailed analysis of the features of this turn-helix peptide motif that are necessary for IGFBP-1 binding and structural integrity. Further rounds of phage randomization indicate the importance of residues contributing to a hydrophobic patch on one face of the helix. Alanine-scanning substitutions confirm that the hydrophobic residues are necessary for binding. However, structural analysis by NMR spectroscopy indicates that some of these analogues are less well folded. Structured, high-affinity analogues that lack the disulfide bond were prepared by introducing a covalent constraint between side chains at positions i and i + 7 or i + 8 within the helix. Analogues based on this scaffold demonstrate that a helical conformation is present in the bound state, and that hydrophobic side chains in this helix, and residues immediately preceding it, interact with IGFBP-1. By comparison of alanine scanning data for IGF-I and the turn-helix peptide, we propose a model for common surface features of these molecules that recognize IGFBP-1.
+
The line below this paragraph, {{ABSTRACT_PUBMED_11456486}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 11456486 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_11456486}}
==About this Structure==
==About this Structure==
-
Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1IN3 OCA].
+
Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1IN3 OCA].
==Reference==
==Reference==
Line 32: Line 36:
[[Category: Zobel, K.]]
[[Category: Zobel, K.]]
[[Category: Covalently constrained helix]]
[[Category: Covalently constrained helix]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 20:10:37 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 1 13:35:03 2008''

Revision as of 10:35, 1 July 2008

Image:1in3.png

Template:STRUCTURE 1in3

Peptide Antagonist of IGFBP1, (i,i+8) Covalently Restrained Analog

Template:ABSTRACT PUBMED 11456486

About this Structure

Full experimental information is available from OCA.

Reference

Structure-function analysis of a phage display-derived peptide that binds to insulin-like growth factor binding protein 1., Skelton NJ, Chen YM, Dubree N, Quan C, Jackson DY, Cochran A, Zobel K, Deshayes K, Baca M, Pisabarro MT, Lowman HB, Biochemistry. 2001 Jul 24;40(29):8487-98. PMID:11456486

Page seeded by OCA on Tue Jul 1 13:35:03 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1in3"
Personal tools